会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 12. 发明授权
    • Methods for ex vivo propagation of somatic hair follicle stem cells
    • 体细胞毛囊干细胞体外增殖的方法
    • US07655465B2
    • 2010-02-02
    • US11147013
    • 2005-06-07
    • James L. SherleyJohnathan King
    • James L. SherleyJohnathan King
    • C12N5/06
    • C12N5/0628A61K35/12C12N2500/40
    • The present invention is directed to methods for readily propagating somatic hair follicle stem cells or melanocyte stem cells. The methods comprise enhancing guanine nucleotide (GNP) biosynthesis, thereby expanding guanine nucleotide pools. This in turn conditionally suppresses asymmetric cell kinetics in the explanted cells. The methods of the invention include pharmacological methods and genetic methods. For example, the resulting cultured somatic hair follicle stem cells can be used for a variety of applications including cell replacement therapies such as hair transplants, gene therapies, and tissue engineering applications, such as the generation of artificial skin and skin regeneration strategies including skin grafts.
    • 本发明涉及容易繁殖体细胞毛囊干细胞或黑素细胞干细胞的方法。 该方法包括增强鸟嘌呤核苷酸(GNP)生物合成,从而扩大鸟嘌呤核苷酸库。 这又有条件地抑制了移植细胞中的不对称细胞动力学。 本发明的方法包括药理学方法和遗传方法。 例如,所产生的培养的体细胞毛囊干细胞可用于各种应用,包括细胞替代疗法,例如毛发移植,基因治疗和组织工程应用,例如生成人造皮肤和皮肤再生策略,包括皮肤移植 。
    • 13. 发明授权
    • Cell lines and methods for screening growth regulatory compounds
    • 用于筛选生长调节化合物的细胞系和方法
    • US5741646A
    • 1998-04-21
    • US578207
    • 1995-12-29
    • James L. SherleyLee B. Riley
    • James L. SherleyLee B. Riley
    • G01N33/50C12Q1/68
    • G01N33/5017
    • This invention provides a novel murine cultured cell line which is derived from primary mouse embryo fibroblasts and which exhibits inducer-regulated growth kinetics. The cell line has the potential to grow either linearly or exponentially depending on exposure to an appropriate inducing agent. A corresponding cell line that does not respond to the inducing agent is also provided. The paired cell line system provides a valuable research tool for the development of therapeutic agents that target cells exhibiting deregulated growth kinetics, and also enables the identification of potential carcinogenic agents that alter stem cell renewal kinetics.
    • 本发明提供了一种新型的鼠培养细胞系,其衍生自原代小鼠胚胎成纤维细胞,并且其表现出诱导剂调节的生长动力学。 根据暴露于合适的诱导剂,细胞系具有线性或指数增长的潜力。 还提供了对诱导剂不响应的相应细胞系。 配对的细胞系系统为开发针对显示失调的生长动力学的细胞的治疗剂提供了有价值的研究工具,并且还能够鉴定改变干细胞更新动力学的潜在致癌剂。
    • 14. 发明申请
    • DETECTING AND COUNTING TISSUE - SPECIFIC STEM CELLS AND USES THEREOF
    • 检测和计数组织 - 特异性干细胞及其用途
    • US20130004965A1
    • 2013-01-03
    • US13513289
    • 2010-12-03
    • James L. Sherley
    • James L. Sherley
    • G01N33/566G01N33/573
    • G01N33/56966G01N33/5073G01N33/5076
    • This invention provides methods of determining the number and percent of tissue specific stem cells (TSSCs) in a sample of cells, a population of cells or a sample of tissue. The methods rely on detecting the pattern-specific asymmetric localization of asymmetric self-renewal associated (ASRA) proteins or cell cycle specific proteins (CSSP) in cell undergoing asymmetrical self-renewal, which is a characteristic of TSSCs. The methods can be applied to any situations in which the percent of TSSC is desired such as laboratory research on adult stem cells, in drug development tests, prognostic indicator and therapeutic index, as a diagnostic and prognostic indicator and in monitoring TSSC expansion, e.g., in cell manufacturing processes.
    • 本发明提供了确定细胞样品,细胞群或组织样品中组织特异性干细胞(TSSC)的数量和百分比的方法。 该方法依赖于检测不对称自我更新相关(ASRA)蛋白或细胞周期特异性蛋白(CSSP)在经历不对称自我更新的细胞中的模式特异性不对称定位,这是TSSC的特征。 该方法可以应用于需要TSSC的百分比,如成人干细胞的实验室研究,药物开发测试,预后指标和治疗指标,作为诊断和预后指标以及监测TSSC扩张的任何情况,例如, 在细胞制造过程中。